Veriskin
PrivateLast Round
Seed
Nov 10, 2022
Total Funding Raised
$8.03M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Veriskin operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Seed round in November 2022.
Veriskin is a medical device company that develops TruScore, a non-invasive, handheld diagnostic device that uses AI and hemodynamic measurements to assist clinicians in the rapid detection of skin cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Veriskin Comparables
Compare Veriskin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DermaSensor, Inc. | 88% | |
| Verisante Technology, Inc. | 78% | |
| MetaOptima Technology | 69% |
For institutional investors. Book with your work email.
Veriskin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 10, 2022 | ||||
| Grant | Jul 14, 2022 | ||||
| Grant | Sep 22, 2021 | ||||
| Grant | Mar 1, 2020 | ||||
| Grant | May 1, 2016 |
For institutional investors. Book with your work email.
Veriskin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Arizona Tech Investors | Seed |
| NIH RADx | Grant |
| Frontier Angels | Seed |
| Ariel Savannah Angel Partners | Seed |
| TiE SoCal Angels | Seed |
| DigiLife | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 89% MoM, from 1.3K to 2.5K.
- Nov 10, 2022
$1M round led by Pasadena Angels.
For institutional investors. Book with your work email.
Veriskin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Veriskin's valuation, stock price, and market status.
Is Veriskin a public or private company?
Veriskin is a private company.
What is the current stock price of Veriskin?
Veriskin is a private company, so its shares have no public market price. Caplight tracks Veriskin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Veriskin worth (valuation)?
Valuation information for Veriskin is not publicly available.
Can I buy Veriskin stock?
Veriskin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Veriskin's last funding round?
Veriskin's most recent funding round was Seed on November 10, 2022.
Who are the main investors in Veriskin?
Key investors in Veriskin include National Cancer Institute, Arizona Tech Investors, NIH RADx, Frontier Angels, Ariel Savannah Angel Partners.
Will Veriskin IPO soon?
No public IPO plans have been announced for Veriskin.
How can I track Veriskin secondary market activity?
Caplight tracks bids, offers, and trades in Veriskin's shares on secondary markets.